Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immix Biopharma Inc

IMMX
Current price
1.57 USD -0.12 USD (-7.10%)
Last closed 1.72 USD
ISIN US45258H1068
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 51 057 932 USD
Yield for 12 month -64.32 %
1Y
3Y
5Y
10Y
15Y
IMMX
21.11.2021 - 28.11.2021

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing tissue-specific therapeutics in oncology and immune-dysregulated diseases in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and colorectal cancer; and NXC-201 for relapsed/refractory multiple myeloma. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California. Address: 11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7 USD

P/E ratio

Dividend Yield

Current Year

Last Year

-89 517 000 USD

Current Quarter

Last Quarter

Current Year

-5 468 USD

Last Year

-89 519 135 USD

Current Quarter

-24 295 USD

Last Quarter

-23 850 USD

Key Figures IMMX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -20 180 932 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -56.85 %
PEG Ratio
Return On Equity TTM -103.81 %
Wall Street Target Price 7 USD
Revenue TTM
Book Value 0.87 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.83 USD
Diluted Eps TTM -0.83 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IMMX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IMMX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation IMMX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.367
Price Book MRQ 2.1371

Financials IMMX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IMMX

For 52 weeks

1.26 USD 7.75 USD
50 Day MA 1.68 USD
Shares Short Prior Month 552 754
200 Day MA 2.3 USD
Short Ratio 3.01
Shares Short 450 503
Short Percent 5.25 %